Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Cancer control domain
  • 4. Treatment
  • Surgery
  • Radical prostatectomy: open versus laparoscopic surgery

Radical prostatectomy: open versus laparoscopic surgery

  • Charts and Tables

    Charts and Tables

    Figure 4.9

    Percentage of prostate cancer patients receiving radical prostatectomies, by surgical approach (%), by province — 2013-2014 combined

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    † The categories 'Laparoscopic (robotic)' and 'Laparoscopic (non-robotic)' were combined due to small numbers and/or to avoid residual disclosure in NB and MB.
    Data source: Canadian Institute of Health Information (CIHI).

    Data Table

    ProvinceType of radical prostatectomy CasesPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BCLaparoscopic (non-robotic)727.25.79.0
    BCLaparoscopic (robotic)585.84.47.4
    BCOpen87087.084.889.0
    ABLaparoscopic (non-robotic)304.436.2
    ABLaparoscopic (non-robotic)304.43.06.2
    ABLaparoscopic (robotic)40058.554.762.2
    ABOpen25437.133.540.9
    SKLaparoscopic (non-robotic)16289.584.193.6
    SKOpen1910.56.415.9
    MBLaparoscopic (robotic/non-robotic)†31.70.34.8
    MBOpen17698.395.299.7
    ONLaparoscopic (non-robotic)1456.05.17.0
    ONLaparoscopic (robotic)66827.625.929.5
    ONOpen1,60566.464.568.3
    QCLaparoscopic (non-robotic)20111.810.313.4
    QCLaparoscopic (robotic)50029.427.231.6
    QCOpen1,00058.856.461.1
    NBLaparoscopic (robotic/non-robotic)†2924.817.333.6
    NBOpen8875.266.482.7
    PEOpen17100.080.5100.0
    NSOpen200100.098.2100.0
    NLOpen125100.097.1100.0

    + Expand Table

    † The categories 'Laparoscopic (robotic)' and 'Laparoscopic (non-robotic)' were combined due to small numbers and/or to avoid residual disclosure in NB and MB.
    Data source: Canadian Institute of Health Information (CIHI).

  • Data specifications

    Data specifications

    Data and measurement considerations

    • Indicator results presented here are provided by the Canadian Institute for Health Information (CIHI). They were derived from inpatient and day surgery records from 2013-2014 for men with a documented diagnosis of prostate cancer and who had a procedure indicating prostate removal.
    • Provincial results are based on where the surgery occurred, not where the patient lived at the time.
    • For more details on the methodology see the Technical Notes from CIHI’s Prostate Cancer Surgery Report (www.cihi.ca/web/resource/en/prostate_surgery_technotes_en.pdf).

    Radical Prostatectomy

    • Definition: Proportion of prostate cancer cases that underwent radical prostatectomy in 2013 – 2014 by type of surgery
    • Numerator: Of the denominator, the total number of prostate cancer cases that underwent radical prostatectomy in 2013 – 2014 by type of surgical approach:
      • Open
      • Robotic laparoscopic
      • Non-robotic laparoscopic
    • Denominator: Total number of prostate cancer cases in 2013 – 2014 that underwent a radical prostatectomy procedure
    • Data source: Canadian Institute of Health Information (CIHI)
    • Measurement timeframe: 2013 – 2014
    • Stratification variables: Province
    • Provinces submitting data: All
    • Province-specific notes: N/A
    • General notes:
      1. Results shown by province pertain to the location of surgery, not the province of patient residence.
      2. The denominator consists of all records for male patients of all ages whose discharge record contains a treatment for prostate cancer in the measurement timeframe.
          • Inclusion criteria:
            1. Discharged from acute care
              • ANALYTICAL_INST_TYPE_CODE in (“1”)
            2. Discharge must have a valid male gender recorded
              • Gender in (“M”)
            3. Has a most responsible diagnosis = C61
            4. Has no past history of prostate cancer (Z85.4)
            5. Has a surgery (one of 1.QT.91) on the index procedure
        Intervention Codes
        • Exclusion criteria:
          1. Duplicate records are removed from the analysis. These are identified as discharges with identical values in the following data elements:
            • INST_CODE HEALTH_CARD_ENCRPT_NUM ADMISSION_DATE ADMISSION_TIME
              DISCHARGE_DATE DISCHARGE_TIME HEALTH_CARD_PROV_CODE BIRTHDATE
              GENDER POSTAL_CODE MR_DIAG_ICD10_CODE PRINC_INTERV_CCI_CODE
          2. Newborns, Stillbirths and Cadaveric Donors
            • If ENTRY_CODE not in (“S,” “N”)
            • If ADMISSION_CATEGORY not in (“R”)
          3. Discharges with an invalid encrypted health care number
            • HEALTH_CARD_ENCRYPT_NUM = “0000000000”
          4. All identified procedures with a status attribute code “A” (abandoned)
            • STATUS_ATTRIBUTE not in (“A”)
      3. Volumes are calculated using a methodology similar to that used in CIHI’s report The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer, with small modifications to allow for annual production, as follows:
        1. The annual Quick Stats tables in the CIHI report include only inpatient records from the DAD, whereas the report included inpatient and day surgery records from the DAD, NACRS and AACRS;
        2. The annual Quick Stats tables count discharges, whereas the report counts episodes;
        3. The annual Quick Stats tables use the variable SUBMITTING_PROV_CODE to determine the location of surgery, whereas the report uses Organization ID (OI) data to determine the location of surgery.

        Due to these modifications, the 2 related products are not directly comparable.

  • Related indicators

    Related Indicators

    Prostate patterns of care: radiation and surgical treatment

    Percentage of low-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
    View this indicator
    Prostate wait times for surgery

    Median and 90th percentile surgery wait times from booking date to surgery for prostate cancer, by province — 2014
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation